Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

Association of chemotherapy cycles and nausea and vomiting with the decrease of post-treatment vitamin D concentration (n = 136). by Herindita Puspitaningtyas (11618232)

The decrease in embryonic survival after stress coincides with a decrease in oocyte and embryo size. by Sarah Fausett (11812818)

Hepatic B1 cells increase whereas PC B1 cells decrease after <i>S</i>. <i>japonicum</i> infection. by Liang Yong (6836771)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

The monoterpene 1,8-cineole decreased parasitemia levels in vitro. by Edgleyson C. dos Santos (12536575)

SIS3 decreases phosphorylation of CRMP2 without activating GSK-3β. by Kye-Im Jeon (441227)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

VPA decreases cell proliferation. by Muriel Rhinn (406515)

Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

Nicorandil inhibits the decrease of SYP. by Yuanzheng Zhao (10035836)

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges. by Jaclyn M. Kline (9565161)

“…(B) Tactile sensitivity in sensitized mice preventatively treated with imatinib or NT and then 10 daily MI challenges. Results reported as mean ± SEM of the percent decrease from baseline in the withdrawal threshold for each treatment group, n = 18/treatment group. …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

GSK3β inhibition by CHIR 99021 decreases apoptosis, and at high dose, but not low dose, decreases proliferation. by Chloe Delepine (10751420)

DCD is strikingly decreased in HS lesions. by Margaret Coates (6058580)

Ellagic acid decreases lysosomal integrity. by Ahmad Salimi (10204515)